2021 ERS临床实践指南:结节病的治疗

2021-06-17 欧洲呼吸学会 Eur Respir J.2021 Jun 17;2004079.

2021年6月,欧洲呼吸学会(ERS)发布了结节病的治疗指南,结节病治疗的主要原因是降低发病率和死亡风险,改善患者生活质量。糖皮质激素仍是症状性疾病初始治疗的首选,但长期应用于显著的毒性作用相关。本文

中文标题:

2021 ERS临床实践指南:结节病的治疗

英文标题:

ERS clinical practice guidelines on treatment of sarcoidosis

发布机构:

欧洲呼吸学会

发布日期:

2021-06-17

简要介绍:

2021年6月,欧洲呼吸学会(ERS)发布了结节病的治疗指南,结节病治疗的主要原因是降低发病率和死亡风险,改善患者生活质量。糖皮质激素仍是症状性疾病初始治疗的首选,但长期应用于显著的毒性作用相关。本文主要针对结节病的治疗,考考肺、皮肤、心脏以及神经肌病和批量的管理提供指导建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ERS临床实践指南:结节病的治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9cfb91c002128293, title=2021 ERS临床实践指南:结节病的治疗, enTitle=ERS clinical practice guidelines on treatment of sarcoidosis, guiderFrom=Eur Respir J.2021 Jun 17;2004079., authorId=0, author=, summary=2021年6月,欧洲呼吸学会(ERS)发布了结节病的治疗指南,结节病治疗的主要原因是降低发病率和死亡风险,改善患者生活质量。糖皮质激素仍是症状性疾病初始治疗的首选,但长期应用于显著的毒性作用相关。本文, cover=https://img.medsci.cn/2021715/1626282903588_2020535.jpg, journalId=0, articlesId=null, associationId=172, associationName=欧洲呼吸学会, associationIntro=欧洲呼吸学会(ERS)是欧洲专业学会组织,是具有广泛基础的拥有100多个国家的大约一万名成员。内容涵盖了基础科学和临床医学。, copyright=0, guiderPublishedTime=Thu Jun 17 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年6月,欧洲呼吸学会(ERS)发布了结节病的治疗指南,结节病治疗的主要原因是降低发病率和死亡风险,改善患者生活质量。糖皮质激素仍是症状性疾病初始治疗的首选,但长期应用于显著的毒性作用相关。本文主要针对结节病的治疗,考考肺、皮肤、心脏以及神经肌病和批量的管理提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=10513, tagName=结节病)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=10513, guiderKeyword=结节病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7110, appHits=279, showAppHits=0, pcHits=643, showPcHits=6830, likes=0, shares=12, comments=11, approvalStatus=1, publishedTime=Thu Jul 15 01:51:49 CST 2021, publishedTimeString=2021-06-17, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 15 01:15:09 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 16:55:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ERS临床实践指南:结节病的治疗.pdf)])
2021 ERS临床实践指南:结节病的治疗.pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1223424, encodeId=a83b1223424f8, content=请问有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=619b5400576, createdName=ms9000000970105107, createdTime=Mon May 30 19:49:05 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200434, encodeId=32ca1200434db, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:24:47 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076782, encodeId=8a9d10e6782d3, content=学习了,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3935460121, createdName=ms3000000818214730, createdTime=Sat Dec 04 11:08:09 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075808, encodeId=60c010e5808dc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f66157933, createdName=ms9000001679113742, createdTime=Wed Dec 01 11:11:24 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072447, encodeId=9bcf10e2447a8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33145677665, createdName=zuomingyuan2787, createdTime=Sun Nov 21 09:49:18 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2022-05-30 ms9000000970105107

    请问有中文的吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1223424, encodeId=a83b1223424f8, content=请问有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=619b5400576, createdName=ms9000000970105107, createdTime=Mon May 30 19:49:05 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200434, encodeId=32ca1200434db, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:24:47 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076782, encodeId=8a9d10e6782d3, content=学习了,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3935460121, createdName=ms3000000818214730, createdTime=Sat Dec 04 11:08:09 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075808, encodeId=60c010e5808dc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f66157933, createdName=ms9000001679113742, createdTime=Wed Dec 01 11:11:24 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072447, encodeId=9bcf10e2447a8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33145677665, createdName=zuomingyuan2787, createdTime=Sun Nov 21 09:49:18 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2022-03-08 genglihui01

    感谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1223424, encodeId=a83b1223424f8, content=请问有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=619b5400576, createdName=ms9000000970105107, createdTime=Mon May 30 19:49:05 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200434, encodeId=32ca1200434db, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:24:47 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076782, encodeId=8a9d10e6782d3, content=学习了,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3935460121, createdName=ms3000000818214730, createdTime=Sat Dec 04 11:08:09 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075808, encodeId=60c010e5808dc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f66157933, createdName=ms9000001679113742, createdTime=Wed Dec 01 11:11:24 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072447, encodeId=9bcf10e2447a8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33145677665, createdName=zuomingyuan2787, createdTime=Sun Nov 21 09:49:18 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2021-12-04 ms3000000818214730

    学习了,感谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1223424, encodeId=a83b1223424f8, content=请问有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=619b5400576, createdName=ms9000000970105107, createdTime=Mon May 30 19:49:05 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200434, encodeId=32ca1200434db, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:24:47 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076782, encodeId=8a9d10e6782d3, content=学习了,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3935460121, createdName=ms3000000818214730, createdTime=Sat Dec 04 11:08:09 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075808, encodeId=60c010e5808dc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f66157933, createdName=ms9000001679113742, createdTime=Wed Dec 01 11:11:24 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072447, encodeId=9bcf10e2447a8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33145677665, createdName=zuomingyuan2787, createdTime=Sun Nov 21 09:49:18 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2021-12-01 ms9000001679113742

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1223424, encodeId=a83b1223424f8, content=请问有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=619b5400576, createdName=ms9000000970105107, createdTime=Mon May 30 19:49:05 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200434, encodeId=32ca1200434db, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:24:47 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076782, encodeId=8a9d10e6782d3, content=学习了,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3935460121, createdName=ms3000000818214730, createdTime=Sat Dec 04 11:08:09 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075808, encodeId=60c010e5808dc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f66157933, createdName=ms9000001679113742, createdTime=Wed Dec 01 11:11:24 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072447, encodeId=9bcf10e2447a8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33145677665, createdName=zuomingyuan2787, createdTime=Sun Nov 21 09:49:18 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2021-11-21 zuomingyuan2787

    学习

    0

拓展阅读

2020 ATS临床实践指南:结节病的诊断和检测

美国胸科学会(ATS,American Thoracic Society) · 2020-04-15

美国/欧洲最新结节病诊治指南与共识解析

中国人民解放军总医院第六医学中心呼吸与危重症医学科 · 2023-08-15